放射性125 I粒子联合热疗治疗晚期肺癌的临床观察  

Clinical observation of 125 I particles with advanced lung cancer treated with radioactive seed

作　　者：李美术[1] 李万刚[2,3] 

机构地区：[1]河南省固安县人民医院外科,河北固安065500 [2]中国天然气集团公司中心医院 [3]河北医科大学石油临床医学院胸外科,河北廊坊050017

出　　处：《转化医学电子杂志》2016年第8期47-48,共2页E-Journal of Translational Medicine

摘　　要：目的:探究放射性125 I粒子联合热疗治疗晚期肺癌的临床价值.方法:选取2014-03/2015-02河北省固安县人民医院收治的晚期肺癌患者40例作为研究对象,采用简单随机化法将患者分为实验组(n=20)和对照组(n=20),实验组接受放射性125 I粒子联合热疗治疗,对照组仅接受单纯粒子植入治疗,对比两组治疗情况的差异性.结果:实验组肺癌患者治疗效果以及生活质量改善情况均优于对照组,差异有统计学意义(P<0.05).结论:晚期肺癌患者接受放射性125 I粒子联合热疗治疗效果较好,利于缩小患者的肿瘤,改善其生活质量.AIM： To explore the clinical value of radioactive 125 I combined with hyperthermia in the treatment of patients with advanced lung cancer. METHODS： A total of 40 patients with advanced lung cancer admitted into People＇s Hospital of Gu＇an County from March 2014 to February 2015 were selected as study objects and randomly divided into experimental group and control group,with 20 patients in each group. The experimental group accepted radioactive 125 I particles combined with hyperthermia in the treatment,while the control group only received simple particle implantation in the treatment,and the differences between the two groups were compared. RESULTS： The treatment effect and quality of life of patients with lung cancer in the experimental group were better than those in the control group,and the difference was statistically significant（ P 0. 05）. CONCLUSION：Patients with advanced lung cancer were treated with radioactive 125 I particles combined with hyperthermia treatment,which is conducive to reduce tumor and improve the quality of life.

关 键 词：放射性125 I粒子 热疗 晚期肺癌 

分 类 号：R735.8[医药卫生—肿瘤]